new post
StocksRunner logo
mail
search
 
menu
 
Vertex Pharma
$491.47
+5.69%
 
  Set Alerts  
  
  Overview  
  
  Comments  
  
  Insights  
  
     Risks     
  
  Rating  
  
     Chart     
  
  Analysts  
  
  Street  
  
  Sentiment  
  
  Headlines  
 

VRTX Stock Analysis & IQ Rating | Vertex Pharma

 
 

VRTX

 

Vertex Pharma

$491.47

 
+$26.45 | +5.69%
 
Set Alerts
 
  Overview  
  
  Comments  
  
  Insights  
  
     Risks     
  
  Rating  
  
     Chart     
  
  Analysts  
  
  Street  
  
  Sentiment  
  
  Headlines  
 
 
52W High
$519.68
 
 
MKT CAP
$126.70B
 
52W Low
$362.5
 
 
VOL
$2.87M
 
P/E Ratio
34.53
 
 
AVG VOL
$1.51M
 
RSI
62.53
 
 
TREND
Uptrend
 
 
 

VRTX Stock IQ

 
lock  Login to see Vertex Pharma (VRTX) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid
 
 

VRTX Target Price

 
 
 

Strengths

 
 

VRTX Rewards

 Upgraded on attractively valued

VRTX Rewards

 Earnings are forecast to grow

VRTX Rewards

 Outperform the market

VRTX Rewards

 Trading below its fair value

 

Risk Analysis

 

VRTX Risk Analysis

 Investors losing their confidence

 
 

VRTX Price Performance

 
 

$441.36   (+11.35%)

$435.52   (+12.85%)

$383.13   (+28.28%)

$483.31   (+1.69%)

 
 
1year
6month
3month
1month
 

VRTX Analysts Opinion

 

Overall standing based on market and analyst consensus. menu Hover over the category for more information

 
 
 

Earnings

×
 

Earnings

 

VRTX Earnings Sentiment

 Above analyst estimates

VRTX Earnings Sentiment

 Reported a strong earnings

VRTX Earnings Sentiment

 Eps growth

 
 

Rating

×
 

Rating

 

VRTX Rating Sentiment

 Upgraded on attractively valued

 

Momentum

×
 

Momentum

 

VRTX Momentum Analysis

 Price value has negative momentum

 

Activity

×
 

Activity

 

VRTX Activity Sentiment

 Investors losing their confidence

 

Future

×
 

Future

 

VRTX Future Sentiment

 Earnings are forecast to grow

VRTX Future Sentiment

 Outperform the market

VRTX Future Sentiment

 Trading below its fair value

 
 

VRTX Analysts Opinion

VRTX Analysts opinion is positive but there was a setback from the past 3 months

 

VRTX Street Sentiment

 

Analysts perspectives on the stock desirability, trend direction and growth potential

 
 
75%
Buy
Opinion
Trend
Score
Potential
Score
 
Consensus Rating
 
86%
38%
91%
 

VRTX Street Sentiment 

VRTX Street Sentiment is bullish and have positive views on the near-term outlook

 

VRTX Risk Level

 
 

VRTX has Low risk level

 
 
 
VRTX Risk Level
Low
LOW
HIGH
 

VRTX Performance Sentiment

 
Sentiments overview associated with events and the stock performance
 
 
75%
23%
Positive
Negative
48 out of 64
events present
15 out of 64
events present
 
Very Bullish
Bullish
Neutral
Bearish
Very Bearish
 
 

Key Price Levels

 

Average key support and resistance price levels

 
 
Support
Price
 
$465.02
 
Resistance
Price
 
$438.92
 
 
Current Price Range
 
$477.92
 
 
Show methods +
 
 
 

Analyst Consensus

 

Recent Upgrades and Downgrades

 
 
80%
Buy
Hold
Sell
 
Consensus Rating

STRONG BUY

12
3
0
 

Date

 

Action

 

Rating

 

Firm

Feb 11, 2026

 

Downgrade

 

Neutral

 

Piper Sandler

 

Jan 29, 2026

 

Upgrade

 

Overweight

 

Barclays

 

Jan 23, 2026

 

Upgrade

 

Outperform

 

RBC

 

Jan 06, 2026

 

Upgrade

 

Outperform

 

Wolfe Research

 

Nov 26, 2025

 

Initiate

 

Buy

 

Scotiabank

 
 
 
VRTX Latest Analysis +
 
 
FAQ About VRTX Stock Insights
 

What is VRTX current stock price?

What are VRTX stock strengths?

What is VRTX Risk Level?

What is VRTX market cap and volume?

What is VRTX current Stock IQ?

Should I buy VRTX stock right now?

Is VRTX a Strong Buy right now?

What does a 'Strong Buy' rating mean for VRTX?

What does a 'Strong Sell' rating mean for VRTX?

What factors influence VRTX's Stock IQ?

 
 
StocksRunner

Explore our VRTX Stock insights

  • In-Depth Market Analysis and Trends
  • Expert Insights on Market Dynamics
  • Tailored VRTX Stock Strategies
  • Effective Risk Management
 

FIND US ON

StocksRunner on Facebook StocksRunner on Twitter StocksRunner on YouTube StocksRunner on stocktwits StocksRunner Rss
 

Receive our VRTX Daily Alerts

Join over 5,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts

 
Market Trends

Stay ahead of the market

Market trends

Investment tips

Market analysis service

 
Investment Insights

Future potential

Informed investment decisions

Investment analysis

IInvestment strategies

 
Stock Analysis

In-depth stock analysis

Performance analysis

Stock market insights

Financial trends analysis

 
About StocksRunner

Log In

Sign Up

Plans & Pricing

Contact Us

Terms of use

Privacy Policy

 
 
 
 

VRTX

 

Vertex Pharma

 
Set Alerts
 
 

Current Price

 

$491.47

 
+$26.45 | +5.69%
 
 
52W High
$519.68
 
 
MKT CAP
$126.70B
 
52W Low
$362.5
 
 
VOL
$2.87M
 
P/E Ratio
34.53
 
 
AVG VOL
$1.51M
 
RSI
62.53
 
 
TREND
Uptrend
 
 
 
  Overview  
  
  Comments  
  
  Insights  
  
   Risks   
  
  Rating  
  
  Chart  
  
  Analysts  
  
  Street  
  
  Sentiment  
 
 
 
 
user
 
 
 
 

VRTX Price Performance

 
 

$441.36   (+11.35%)

$435.52   (+12.85%)

$383.13   (+28.28%)

$483.31   (+1.69%)

 
 
1year
6month
3month
1month
 

VRTX Analysts Opinion

 

Overall standing per market and analyst expectations. menu Hover over the category for more information

 
 
 

Earnings

×
 

Earnings

 

VRTX Earnings Sentiment

 Above analyst estimates

VRTX Earnings Sentiment

 Reported a strong earnings

VRTX Earnings Sentiment

 Eps growth

 
 

Rating

×
 

Rating

 

VRTX Rating Sentiment

 Upgraded on attractively valued

 

Momentum

×
 

Momentum

 

VRTX Momentum Sentiment

 Price value has negative momentum

 

Activity

×
 

Activity

 

VRTX Activity Sentiment

 Investors losing their confidence

 

Future

×
 

Future

 

VRTX Future Sentiment

 Earnings are forecast to grow

VRTX Future Sentiment

 Outperform the market

VRTX Future Sentiment

 Trading below its fair value

 
 

VRTX Analysts Opinion

VRTX Analysts opinion is positive but there was a setback from the past 3 months

 

VRTX Street Sentiment

 

Analysts perspectives on the stock desirability, trend direction and growth potential

 
 
75%
Buy
Opinion
Trend
Score
Potential
Score
 
Consensus Rating
 
86%
38%
91%
 

VRTX Street Sentiment 

VRTX Street Sentiment is bullish and have positive views on the near-term outlook

 

VRTX Risk Level

 
 

VRTX has Low risk level

 
 
 
VRTX Risk Level
Low
LOW
HIGH
 
VRTX Performance Sentiment
 
Sentiments overview associated with events and the stock performance.
 
 
75%
23%
Positive
Negative
48 out of 64
events present
15 out of 64
events present
 
Very Bullish
Bullish
Neutral
Bearish
Very Bearish
 

Key Price Levels

 

Average key support and resistance price levels

 
 
Support
Price
 
$465.02
 
Resistance
Price
 
$438.92
 
 
Current Price Range
 
$477.92
 
 
Show methods +
 
 

Latest Analyst Actions

 

Overall Wall Street Rating

 
 
80%
Buy
Hold
Sell
 
Consensus Rating

STRONG BUY

12
3
0
 
Date
Action
Rating
Firm
 

Feb 11, 2026

Downgrade

Neutral

Piper Sandler

 

Jan 29, 2026

Upgrade

Overweight

Barclays

 

Jan 23, 2026

Upgrade

Outperform

RBC

 

Jan 06, 2026

Upgrade

Outperform

Wolfe Research

 

Nov 26, 2025

Initiate

Buy

Scotiabank

 
 
 
 
 
 

VRTX Stock IQ

 
 
 
lock  Login to unlock Vertex Pharma (VRTX) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid
 
 
 

Target Price

 
 
 
 
 
 
 

Stock Insights

 
 
 
 

Strengths

 
 

VRTX Rewards

 Upgraded on attractively valued

VRTX Rewards

 Earnings are forecast to grow

VRTX Rewards

 Outperform the market

VRTX Rewards

 Trading below its fair value

 

Risk Analysis

 
 

VRTX Risk Analysis

 Investors losing their confidence

 
 
 

VRTX Latest Analysis

 
 
 

Oppenheimer Upgrades Vertex Pharmaceuticals (VRTX). Fintel reports that on February 13 2026 Oppenheimer upgraded their outlook for Vertex Pharmaceuticals (NasdaqGS:VRTX) from Perform to Outperform. Analyst Price Forecast Suggests 14.51% Upside

 

Today

$491.47 | +5.69%
 
Potential
Rating

VRTXs Q4 Earnings Miss Mark Revenues Beat on Higher Product Sales. Vertex Q4 earnings miss estimates but revenues top forecasts on strong CF sales and momentum from new launches like Alyftrek Casgevy and Journavx.

 

Today

$491.47 | +5.69%
 
Activity
Earnings
Earnings
Momentum

Agree To Purchase Vertex Pharmaceuticals At $320 Earn 4.4% Using Options. Investors eyeing a purchase of Vertex Pharmaceuticals Inc. (Symbol: VRTX) stock but cautious about paying the going market price of $494.38/share might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in p

 

Today

$491.47 | +5.69%
 
Activity
Activity
Potential

Vertex Pharma (VRTX) Renal Pipeline Seen as Major Growth Driver by Barclays. Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) ranks among the best high growth high margin stocks to buy now. On January 28 Barclays began coverage of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) with an Overweight rating and a $606 price target voicing confidence about Vertexs renal franchise implying that it might achieve significant market attention in 2026 and perhaps follow [….]

 

Today

$491.47 | +5.69%
 
Potential
Rating

Vertex Pharmaceuticals (VRTX) Stock Drops After Hours — Heres Why Its Trending Tonight. Vertex Pharmaceuticals Inc. (NASDAQ:VRTX) shares are trending on Thursday night.Shares of the Massachusetts-based biotechnology company fell 1.24% in after-hours trading to $459.25 on Thursday despite reporting fourth-quarter revenue of $3.19 billion up 10% year-over-year according to a company

 

Today

$491.47 | +5.69%
 
Momentum

Vertex (VRTX) Q4 Earnings: How Key Metrics Compare to Wall Street Estimates. Although the revenue and EPS for Vertex (VRTX) give a sense of how its business performed in the quarter ended December 2025 it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

 

Thu Feb 12, 2026

$465.02 | +0.82%
 
Potential

Vertex Pharmaceuticals (VRTX) Q4 Earnings Miss Estimates. Vertex (VRTX) delivered earnings and revenue surprises of -0.74% and 0.70% respectively for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?

 

Thu Feb 12, 2026

$465.02 | +0.82%
 
Earnings
 
 
 
 
 
StocksRunner

Discover VRTX Stock analysis and effective trading strategies with StocksRunner.com. Gain valuable insights into stock performance, market trends and the future potential of VRTX. We're here to help you make informed investment decisions today.

 

FIND US ON

StocksRunner on Facebook StocksRunner on Twitter StocksRunner on YouTube StocksRunner on stocktwits StocksRunner Rss

 

Receive our VRTX Daily Alerts

Unlock the knowledge that 5,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts

 
Market trends

In-depth stock analysis

Informed investment decisions

Stock market insights

Stock trading tips

Stock analysis

VRTX Stock trends

VRTX Stock performance

VRTX Stock analysis

VRTX investment strategies

Stock strategies

Trading strategies

StocksRunner updates

StocksRunner Insights

Financial Reports

 
 

Disclaimer: Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor. The Readiness Indicators, Sentiment Indicators and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses. Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.

Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").

This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.

 
 
StocksRunner logo
 

VRTX Alerts

Real-time signals powered by data
×

Price-Based

Triggers when the stock breaks through a known resistance level
 
Triggers when the stock drops below a key support level
 
Notifies if the stock moves up/down by a set percentage (e.g. ±5%)
 
Alerts when the stock hits a new high or low
 
Signals proximity to long-term highs or lows (e.g. within 5%)
 

Technical Indicator (Pro Plan)

Volume spikes 2x–3x above average. Indicates strong buying/selling pressure
 
Tracks large intraday swings, signaling potential opportunities or risk
 
Signals potential trend reversals or continuations
 
Long-term bullish/bearish trend signals from MA crossovers
 
RSI above 70 or below 30 to identify possible reversals
 
Signals momentum shifts
 

Fundamental Indicator (Master Plan)

Upcoming or just-released earnings reports
 
Alerts after results compared to expectations
 
Changes in rating or target price
 
New or changed dividends
 
Large trades by company insiders
 
M&A, lawsuits, product launches, etc
 
High volume/open interest in call/put contracts
 
Surge in mentions or sentiment shifts
 
 
Cancel
 
×
 
0/666
joker
 
Post
 
✕
 
StocksRunner logo
 

Don't Be a Sheep, Be a StocksRunner

 

StocksRunner Aggregates The Most Important Headlines Into A Single Stock IQ

 
StocksRunner thumbnail
 
 

Sign up for free and

continue analysing VRTX

 
Signup to Stocksrunner
 

Already a Member? Click here to Login

 

Join us on this journey to revolutionize the way you approach investing. Together, let's navigate the stock market with clarity, confidence and cutting-edge intelligence.

 
✕
 
StocksRunner logo
 

Don't Be a Sheep, Be a StocksRunner

 

StocksRunner Aggregates The Most Important Headlines Into A Single Stock IQ

 
StocksRunner thumbnail
 
 

Sign up for free and

continue analysing VRTX

 
Signup to Stocksrunner
 

Already a Member? Click here to Login

 

Join us on this journey to revolutionize the way you approach investing. Together, let's navigate the stock market with clarity, confidence and cutting-edge intelligence.